Physician profile
Caroline Just
NPI 1437722584
$420.48
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $408 · 2022: $12.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $121.60 | 2021 | |
| Abbvie INC. | $84.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.09 | 2021 | |
| Biogen, INC. | $20.68 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.51 | 2021 | |
| Lilly USA, LLC | $18.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.49 | 2021 | |
| Lundbeck LLC | $17.17 | 2021 | |
| Genzyme Corporation | $16.13 | 2021 | |
| Ucb, INC. | $13.41 | 2021 | |
| Zogenix INC. | $12.60 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.26 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.18 | 2021 | |
| Neurocrine Biosciences, INC. | $11.22 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Just listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.